{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:25:12Z","timestamp":1787905512589,"version":"build-2784847793"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Type 1 diabetes (T1D) has long been recognized as a T-cell-driven autoimmune disease. However, growing evidence highlights the involvement of metabolic, inflammatory, and gut microbiota-related factors in its progression. The endocannabinoid system (ECS), a key regulator of immune and metabolic homeostasis, has been increasingly implicated in autoimmune pathophysiology, particularly through its interactions with gut-derived metabolites. This hypothesis article underscores the need to reframe T1D pathophysiology by integrating ECS dysfunction, gut dysbiosis, and metabolic imbalances into a systems biology framework. The proposed Endocannabinoidome-Microbiota (ECBoM) model highlights a shared hallmark of autoimmunity\u2014SCFA depletion, increased intestinal permeability, and ECS dysregulation\u2014as key drivers of chronic inflammation and immune dysfunction. These disturbances, observed in T1D as well as in celiac disease, Hashimoto\u2019s thyroiditis, rheumatoid arthritis, and multiple sclerosis, suggest a common immune-metabolic axis across autoimmune disorders. Recognizing ECS dysregulation as a systemic feature of autoimmunity opens avenues for novel therapeutic interventions, including ECS-targeted treatments, microbiota modulation, and phytocannabinoid-based therapies. This article highlights the necessity of conducting large-scale, multi-omics studies to establish disease-specific ECS signatures, linking endocannabinoid profiling, microbiota composition, and metabolic biomarkers to disease progression. By advocating for a paradigm shift in T1D research, this article emphasizes the importance of exploring new mechanistic references to develop targeted, immune-metabolic interventions that could reshape treatment strategies and improve clinical outcomes in T1D and related autoimmune diseases.<\/jats:p>","DOI":"10.3389\/fendo.2025.1576419","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:12:46Z","timestamp":1748491966000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Reframing type 1 diabetes through the endocannabinoidome-microbiota axis: a systems biology perspective"],"prefix":"10.3389","volume":"16","author":[{"given":"Wojciech","family":"\u0141ukowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.v173.7","article-title":"Role of the endocannabinoid system in diabetes and diabetic complications","volume":"173","author":"Gruden","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1847","article-title":"Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes","volume":"64","author":"Alkanani","year":"2015","journal-title":"Diabetes"},{"key":"B3","doi-asserted-by":"publisher","first-page":"zqad003","DOI":"10.1093\/function\/zqad003","article-title":"The gut microbiome\u2013endocannabinoidome axis: A new way of controlling metabolism, inflammation, and behavior","volume":"4","author":"Silvestri","year":"2023","journal-title":"Funct (Oxf)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.211","article-title":"Endocannabinoids\u2013at the crossroads between the gut microbiota and host metabolism","volume":"12","author":"Cani","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","author":"Pertwee","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1612177114","article-title":"Endocannabinoid system acts as a regulator of immune homeostasis in the gut","volume":"114","author":"Acharya","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.090472","article-title":"Endocannabinoid overactivity and intestinal inflammation","volume":"55","author":"Marzo","year":"2006","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqac217","article-title":"The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs","volume":"116","author":"Palmn\u00e4s-B\u00e9dard","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern Emerg Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/msb.2010.46","article-title":"The endocannabinoid system links gut microbiota to adipogenesis","volume":"6","author":"Muccioli","year":"2010","journal-title":"Mol Syst Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00598\/full","article-title":"Leaky gut as a danger signal for autoimmune diseases","volume":"8","author":"Mu","year":"2017","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2008.03.001","article-title":"FAAH and anandamide: is 2-AG really the odd one out","volume":"29","author":"Marzo","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1065323","article-title":"Type 1 diabetes alters brain cannabinoid receptor expression and phosphorylation status in rats","volume":"40","author":"D\u00edaz-Asensio","year":"2008","journal-title":"Hormone Metab Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2014.921165","article-title":"Role of endocannabinoid activation of peripheral CB1 receptors in the regulation of autoimmune disease","volume":"34","author":"Sido","year":"2015","journal-title":"Int Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2024.01.008","article-title":"TRPV1: The key bridge in neuroimmune interactions","volume":"4","author":"Chen","year":"2024","journal-title":"J Intensive Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891698\/full","article-title":"Gene expression signatures reveal common virus infection pathways in target tissues of type 1 diabetes, hashimoto\u2019s thyroiditis, and celiac disease","volume":"13","author":"Yin","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0331","article-title":"The \u2018perfect storm\u2019 for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity","volume":"57","author":"Vaarala","year":"2008","journal-title":"Diabetes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.699661","article-title":"An autonomous cannabinoid system in islets of langerhans","volume":"12","author":"Aseer","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"101906","DOI":"10.1016\/j.molmet.2024.101906","article-title":"Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice","volume":"82","author":"Aseer","year":"2024","journal-title":"Mol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biocel.2014.03.028","article-title":"2-Arachidonoylglycerol modulates human endothelial cell\/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors","volume":"51","author":"Gasperi","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"B24","unstructured":"Regulation of Calcium-Permeable TRPV2 Channel by Insulin in Pancreatic \u03b2-Cells | Diabetes | American Diabetes Association\n          \n          \n          \n          2009"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.809965","article-title":"Anti-inflammatory and pro-autophagy effects of the cannabinoid receptor CB2R: possibility of modulation in type 1 diabetes","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2014.02.004","article-title":"Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond","volume":"40","author":"Cani","year":"2014","journal-title":"Diabetes Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13099-019-0332-7","article-title":"Is there any association between gut microbiota and type 1 diabetes? A systematic review","volume":"11","author":"Jamshidi","year":"2019","journal-title":"Gut Pathog"},{"key":"B28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ismej.2010.92","article-title":"Toward defining the autoimmune microbiome for type 1 diabetes","volume":"5","author":"Giongo","year":"2011","journal-title":"ISME J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.3390\/ijms20235875","article-title":"The endocannabinoid system in pediatric inflammatory and immune diseases","volume":"20","author":"Argenziano","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.2337\/dc21-1656","article-title":"The gut microbiome of adults with type 1 diabetes and its association with the host glycemic control","volume":"45","author":"Shilo","year":"2022","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-17214-4_4","article-title":"Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes","volume-title":"Diabetes - Perspectives in Drug Therapy","author":"Di Marzo","year":"2011"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-016-1404-5","article-title":"Marijuana-derived \u0394-9-tetrahydrocannabinol suppresses Th1\/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation","volume":"94","author":"Sido","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0620-2","article-title":"The human gut microbiome in early-onset type 1 diabetes from the TEDDY study","volume":"562","author":"Vatanen","year":"2018","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.01.001","article-title":"The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes","volume":"17","author":"Kostic","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"publisher","first-page":"14771","DOI":"10.1038\/s41598-020-70724-5","article-title":"Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study","volume":"10","author":"Groot","year":"2020","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2018.04.010","article-title":"Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism","volume":"99","author":"Navarini","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.3390\/ijms21114177","article-title":"Calcium entry through TRPV1: A potential target for the regulation of proliferation and apoptosis in cancerous and healthy cells","volume":"21","author":"Zhai","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease \u2013 successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J"},{"key":"B40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system","volume":"50","author":"Pacher","year":"2011","journal-title":"Prog Lipid Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/pharmaceutics15041151","article-title":"Cannabinoids and multiple sclerosis: A critical analysis of therapeutic potentials and safety concerns","volume":"15","author":"Nouh","year":"2023","journal-title":"Pharmaceutics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e62078","DOI":"10.1371\/journal.pone.0062078","article-title":"Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease","volume":"8","author":"Battista","year":"2013","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2011.115","article-title":"Is the origin of type 1 diabetes in the gut","volume":"90","author":"Vaarala","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2180-10-63","article-title":"Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children","volume":"10","author":"De Palma","year":"2010","journal-title":"BMC Microbiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.24-0125","article-title":"Disruption of intestinal barrier and dysbiosis of gut microbiota in an experimental rhesus macaque model with 6-year diabetes mellitus","volume":"9","author":"Fu","year":"2025","journal-title":"Exp Anim"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-23","article-title":"Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity","volume":"9","author":"Sapone","year":"2011","journal-title":"BMC Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21830","article-title":"Differences of small intestinal bacteria populations in adults and children with\/without celiac disease: effect of age, gluten diet, and disease","volume":"18","author":"Nistal","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.642166\/full","article-title":"Intestinal microbiota in common chronic inflammatory disorders affecting children","volume":"12","author":"Torun","year":"2021","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/modpathol.3800959","article-title":"Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms","volume":"21","author":"Tzelepi","year":"2008","journal-title":"Mod Pathol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11154-018-9467-y","article-title":"Gut microbiota and Hashimoto\u2019s thyroiditis","volume":"19","author":"Virili","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"B52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13073-016-0299-7","article-title":"An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis","volume":"8","author":"Chen","year":"2016","journal-title":"Genome Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.121","article-title":"The microbiome and rheumatoid arthritis","volume":"7","author":"Scher","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B54","first-page":"keac454","article-title":"Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control","author":"Audo","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2024.2378876","article-title":"The role of gut microbiota in different murine models of systemic lupus erythematosus","volume":"57","author":"Lu","year":"2024","journal-title":"Autoimmunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/ar2401","article-title":"Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis","volume":"10","author":"Richardson","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm160","article-title":"The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis","volume":"130","author":"Centonze","year":"2007","journal-title":"Brain"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1519040112","article-title":"Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture","volume":"112","author":"Malenczyk","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.beem.2008.10.013","article-title":"An introduction to the endocannabinoid system: from the early to the latest concepts","volume":"23","author":"De Petrocellis","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-20-0444","article-title":"The gut microbiome, endocannabinoids and metabolic disorders","volume":"248","author":"Iannotti","year":"2021","journal-title":"J Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e24894","DOI":"10.4161\/tisb.24894","article-title":"Tight junctions in human pancreatic duct epithelial cells","volume":"1","author":"Kojima","year":"2013","journal-title":"Tissue Barriers"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"crossref","DOI":"10.1111\/pedi.12305","article-title":"The role for gut permeability in the pathogenesis of type 1 diabetes \u2013 A solid or leaky concept","volume":"16","author":"Li","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.3390\/nu14102143","article-title":"Plasma levels of endocannabinoids and their analogues are related to specific fecal bacterial genera in young adults: role in gut barrier integrity","volume":"14","author":"Ortiz-Alvarez","year":"2022","journal-title":"Nutrients"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.19625","article-title":"Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity","volume":"3","author":"Cani","year":"2012","journal-title":"Gut Microbes"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18388\/abp.2018_2648","article-title":"Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)","volume":"66","author":"Ratajczak","year":"2019","journal-title":"Acta Biochim Pol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nature14232","article-title":"Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome","volume":"519","author":"Chassaing","year":"2015","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"14156","DOI":"10.3390\/ijms232214156","article-title":"The PPAR\u03b1 Regulation of the gut physiology in regard to interaction with microbiota, intestinal immunity, metabolism, and permeability","volume":"23","author":"Grabacka","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3390\/nu11081956","article-title":"Lifestyle and metabolic syndrome: contribution of the endocannabinoidome","volume":"11","author":"Di Marzo","year":"2019","journal-title":"Nutrients"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01589.x","article-title":"Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability","volume":"165","author":"Alhamoruni","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.22-0124","article-title":"Impaired healing of cutaneous wound in a Trpv1 deficient mouse","volume":"72","author":"Ueno","year":"2023","journal-title":"Exp Anim"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.02.103","article-title":"The potential pathogenic role of IL-17\/Th17 cells in both type 1 and type 2 diabetes mellitus","volume":"101","author":"Abdel-Moneim","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.v32.7","article-title":"Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes","volume":"32","author":"Maffeis","year":"2016","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1576419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:12:49Z","timestamp":1748491969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1576419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":78,"alternative-id":["10.3389\/fendo.2025.1576419"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1576419","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"article-number":"1576419"}}